Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Grau-Vorster

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|May 31, 2023
Illustrative Potency Assay Examples from Approved TherapiesSílvia Torrents, Marta Grau-Vorster, Joaquim Vives
Advances in Experimental Medicine and Biology|May 31, 2023
Potency Assays: The 'Bugaboo' of Stem Cell TherapySílvia Torrents, Marta Grau-Vorster, Joaquim Vives
Stem Cell Research & Therapy|June 15, 2019
HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site studyMarta Grau-Vorster, Anita Laitinen, Johanna Nystedt, et al.
Molecular Biology Reports|June 21, 2020
Evaluation of a cell-based osteogenic formulation compliant with good manufacturing practice for use in tissue engineeringDaniel Vivas, Marta Grau-Vorster, Irene Oliver-Vila, et al.
Cytotechnology|January 12, 2018
Optimisation of a potency assay for the assessment of immunomodulative potential of clinical grade multipotent mesenchymal stromal cellsIrene Oliver-Vila, Carmen Ramírez-Moncayo, Marta Grau-Vorster, et al.
Frontiers in Immunology|March 13, 2020
Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive ImmunotherapyMarta Grau-Vorster, María López-Montañés, Ester Cantó, et al.
Cytotherapy|November 19, 2018
Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow-derived multipotent mesenchymal stromal cell expansion culturesMarta Grau-Vorster, Luciano Rodríguez, Sílvia Torrents-Zapata, et al.
Cells|May 24, 2019
Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton's JellyMarta Grau-Vorster, Luciano Rodríguez, Anna Del Mazo-Barbara, et al.
Cytotherapy|November 10, 2015
Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jellyIrene Oliver-Vila, Maria Isabel Coca, Marta Grau-Vorster, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|May 31, 2023
Illustrative Potency Assay Examples from Approved TherapiesSílvia Torrents, Marta Grau-Vorster, Joaquim Vives
Advances in Experimental Medicine and Biology|May 31, 2023
Potency Assays: The 'Bugaboo' of Stem Cell TherapySílvia Torrents, Marta Grau-Vorster, Joaquim Vives
Stem Cell Research & Therapy|June 15, 2019
HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site studyMarta Grau-Vorster, Anita Laitinen, Johanna Nystedt, et al.
Molecular Biology Reports|June 21, 2020
Evaluation of a cell-based osteogenic formulation compliant with good manufacturing practice for use in tissue engineeringDaniel Vivas, Marta Grau-Vorster, Irene Oliver-Vila, et al.
Cytotechnology|January 12, 2018
Optimisation of a potency assay for the assessment of immunomodulative potential of clinical grade multipotent mesenchymal stromal cellsIrene Oliver-Vila, Carmen Ramírez-Moncayo, Marta Grau-Vorster, et al.
Frontiers in Immunology|March 13, 2020
Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive ImmunotherapyMarta Grau-Vorster, María López-Montañés, Ester Cantó, et al.
Cytotherapy|November 19, 2018
Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow-derived multipotent mesenchymal stromal cell expansion culturesMarta Grau-Vorster, Luciano Rodríguez, Sílvia Torrents-Zapata, et al.
Cells|May 24, 2019
Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton's JellyMarta Grau-Vorster, Luciano Rodríguez, Anna Del Mazo-Barbara, et al.
Cytotherapy|November 10, 2015
Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jellyIrene Oliver-Vila, Maria Isabel Coca, Marta Grau-Vorster, et al.
Pageof 1